Antimicrobial prophylaxis prevents recurrent urinary tract infections in recent placebo-controlled trial of urinary prophylaxis, we also assessed cost effectiveness using a decision analysis model. In our hospital the direct cost of 1 patient year of urinary prophylaxis approximates the cost of treating one episode of cystitis. In women with a baseline infection rate of 3 per patient year, the annual cost of prophylaxis ($85.82) was less than treatment of acute episodes of infection ($392.30). Sensitivity analyses showed that in women with 3 infections per year, prophylaxis became cost effective when charges per episode exceeded $42.00. In women with frequent episodes of cystitis, prophylaxis will be cost effective in most practice settings.
CITATION STYLE
Stamm, W. E., McKevitt, M., Counts, G. W., Wagner, K. F., Turck, M., & Holmes, K. K. (1981). Is antimicrobial prophylaxis of urinary tract infections cost effective? Annals of Internal Medicine, 94(2), 251–255. https://doi.org/10.7326/0003-4819-94-2-251
Mendeley helps you to discover research relevant for your work.